InvestorsHub Logo
icon url

biopharm

06/05/19 3:30 PM

#330566 RE: EndoTarget #330564

For those that accept what transpired then I guess they may trust in John Springs Stafford.

For those that don't accept what transpired, starting with Ronin Capital John Springs Stafford down playing the IP transfer and never major thoughts out of the current BOD ...then Houston, we have major problems.

Hey they may surprise me and say we had to do it this way for x, y and z reasons which are now known ...

I highly doubt it and the next thing should puzzle any shareholder...knowing we do get those milestones royalties etc etc and exosomes dealings that never fully surfaced etc etc

Maybe Dana Farber / Gordon J Freeman shouldn't have pushed to become co patent owner neither and should had accept blindly what happened?

CDMOs ...one can place a value there

Exosomes and Biomarkers and medical devices of the future ...priceless

So one either wants just a CDMO and sell out cheap or push and battle for patent rights and don't settle just for breadcrumbs